Frequency of venous thromboembolism (VTE) in phase II and III studies evaluating onartuzumab.
收藏数据链接：
官方服务：
资源简介：
Bev = bevacizumab, Ona = onartuzumab, Pac = paclitaxel, Pbo = placebo, Pem = pemetrexed.*Study OAM4861g had 3 arms: Ona + Bev + Pac (n = 62); Ona + Pbo + Pac (n = 58); Pbo + Bev + Pac (n = 62), referred to here as the control arm.Frequency of venous thromboembolism (VTE) in phase II and III studies evaluating onartuzumab.
创建时间：
2015-12-03
